Status:

UNKNOWN

Quality of Life (QOL) After Elective Sigmoidectomy for Diverticular Diseases (DIVERTI)

Lead Sponsor:

University Hospital, Caen

Collaborating Sponsors:

Association Francaise de Chirurgie

Conditions:

Diverticular Disease of Left Side of Colon

Eligibility:

All Genders

18-70 years

Brief Summary

Acute diverticulitis of the left colon is among the most common abdominal disorders. To date, both conservative therapy in uncomplicated stages and emergency surgery in perforated disease with periton...

Detailed Description

Design The DIVERTI-QOL study is a prospective, multicentre, and observational study. The study will start in February 2021. Recruitment will be completed in July 2021. Overall, the inclusion of 110 pa...

Eligibility Criteria

Inclusion

  • inclusion criteria:
  • Patient who has received informed information and has not expressed opposition to participation
  • Francophone patient
  • Patient affiliated to a social security or equivalent system
  • Patient taken in charge for :
  • smoldering DS after DS Hinchey I
  • persistence of symptoms after DS complicated by a peri-sigmoid abscess \<1cm with resolution of inflammation
  • DS complicated with an abscess \>1cm (Hinchey II)
  • Recurrent episodes of DS
  • DS in a patient requiring long-term immunosuppressive therapy (except for neoplastic disease undergoing treatment)
  • Patient operated between 01/02/2021 and 30/07/2021, in elective situation of sigmoid diverticulitis (surgical experimental group) or patient not operated and medically treated (medical control group)
  • Exclusion Criteria:
  • Subjects meeting only one of the following non-inclusion criteria may not be eligible to participate in the research:
  • Patient who is a minor or over 70 years of age
  • Patient undergoing emergency surgery for sigmoid diverticulitis due to a complication (peritonitis, hemorrhage, failure of drainage diverticular abscess)
  • diverticulitis complicated by fistula and/or symptomatic stenosis
  • Colorectal resection protected by an ostomy or Hartmann's intervention
  • Discovery of colorectal cancer on the operating room
  • Patient operated on for diverticulitis of the right colon
  • Neoplastic disease under treatment and/or evolving

Exclusion

    Key Trial Info

    Start Date :

    September 15 2021

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 30 2022

    Estimated Enrollment :

    220 Patients enrolled

    Trial Details

    Trial ID

    NCT04730765

    Start Date

    September 15 2021

    End Date

    September 30 2022

    Last Update

    August 31 2021

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Quality of Life (QOL) After Elective Sigmoidectomy for Diverticular Diseases (DIVERTI) | DecenTrialz